Investor Relations

Here you will find details on our share as well as detailed information on key figures, annual and quarterly results, IR events and much more.

Half Year Results 2020

 

In the first six months of the financial year 2020, HAEMATO AG, Berlin (ISIN: DE0006190705) achieved an IFRS group sales of EUR 115.8 million (previous year: EUR 94.0 million). This corresponds to an increase in sales of almost 23.19 % compared to the same period of the previous year. The result from ordinary business activities (EBITDA) of EUR 2,066 thousand (previous year: EUR 1,675 thousand) was also increased by approx. 23 % compared to the same period of the previous year.

The operating result (EBIT) of EUR 1,230 thousand (previous year: EUR 708 thousand) increased significantly by 73.82 % compared to the same period in the previous year. The noncash depreciation of EUR -3,403 thousand on the fair value of the financial assets led to a net loss of EUR 2,820 thousand as of June 30, 2020.

The equity ratio was 61.3 % as of 30.06.2020. This was thus 5.1 % higher than the equity ratio of 56.17 % as of 31.12.2019.

Performance

Get information about the HAEMATO AG share and get an overview of the current price development.

Rating & Research

Here you will find well-founded stock analyses of renowned research houses and banks on the HAEMATO AG share.

BUY: 48.00 €

First Berlin, 7. September 2020

BUY: 49.00 €

GBC AG, 3. September 2020

BUY: 5.00 €

GBC AG, 22. June 2020

HAEMATO AG

HAEMATO AG
Lilienthalstraße 5c
12529 Schönefeld
Germany

Phone: +49-30 897 30 86 70
Telefax: +49-30 897 30 86 79
E-Mail: info@haemato.ag